Clinical Trials Could Help Stop Alzheimer’s. But Who Will Join Them?
FRIDAY, Nov. 4, 2022 (HealthDay News) — New drugs that could slow or prevent the start of dementia would be groundbreaking, but a new poll suggests many middle-aged adults may be reluctant to take part in the studies that test those medications. Only about 12% of the roughly 1,000 peopleContinue Reading